Vertex Pharmaceuticals Inc / Ma

Perigon Wealth Management, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/16/2026

Shares

6,044

Value ($000)

2,740

Weight

0.0%

2011 Q3 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/16/2026	2,740	0.0%	6,044	12/31/2025
2025 Q3	10/17/2025	2,392	0.0%	6,108	9/30/2025
2025 Q2	7/16/2025	2,673	0.1%	6,004	6/30/2025
2025 Q1	4/23/2025	2,560	0.1%	5,280	3/31/2025
2024 Q4	1/22/2025	2,061	0.1%	4,943	12/31/2024
2024 Q3	10/16/2024	2,255	0.1%	4,849	9/30/2024
2023 Q4	1/29/2024	583	0.0%	1,432	12/31/2023
2023 Q3	10/30/2023	495	0.0%	1,424	9/30/2023
2023 Q2	8/2/2023	545	0.0%	1,548	6/30/2023
2023 Q1	5/3/2023	420	0.0%	1,332	3/31/2023
2022 Q4	2/14/2023	502	0.0%	1,739	12/31/2022
2022 Q3	12/13/2022	461	0.0%	1,592	9/30/2022
2022 Q2	8/11/2022	741	0.1%	2,630	6/30/2022
2022 Q1	5/16/2022	950	0.1%	3,641	3/31/2022
2021 Q4	2/11/2022	684	0.0%	3,115	12/31/2021
2021 Q3	11/1/2021	484	0.0%	2,671	9/30/2021
2021 Q2	7/19/2021	633	0.1%	3,140	6/30/2021
2021 Q1	5/17/2021	461	0.0%	2,144	3/31/2021
2020 Q4	1/28/2021	175	0.0%	741	12/31/2020
2011 Q3	11/14/2022	461	0.0%	1,592	9/30/2011